Products & Outsourced Services

Minerva Biolabs


Minerva Biolabs GmbH started with innovative products for the effective diagnosis and elimination of Mycoplasma contamination in cell cultures and biopharmaceuticals. Minerva Biolabs leads the market in PCR based detection of Mycoplasma and further elimination and prevention of this contamination. Mycoplasma contamination in cell cultures can have several unidentified effects on the reproducibility of results and can cause substantial economic damage during production of biopharmaceuticals/vaccines.

Visit Site